Table: Noile-Immune Biotech - 9-MTH parent results

Noile-Immune Biotech

14/11/2024 06:38

Nov 14 (Reuters)- 
             Noile-Immune Biotech Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Sep 30, 2024        Sep 30, 2023      Dec 31, 2024  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             5 mln              314 mln                      
                 (-98.3 pct)                           (-97.6 pct)  
  Operating     loss 892 mln        loss 495 mln        loss 1.10   
  Recurring     loss 785 mln        loss 848 mln      loss 991 mln  
  Net           loss 787 mln        loss 850 mln      loss 994 mln  
  EPS          loss 18.18 yen      loss 20.81 yen    loss 22.97 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Noile-Immune Biotech Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4893.T